Aristotle University Of Thessaloniki (AUTH)
Ανοσογενετική ανάλυση μεγάλης κλίμακας και μοριακός χαρακτηρισμός των Τ λεμφοκυττάρων σε διαφορετικής πρόγνωσης ασθενείς με Χρόνια Λεμφοκυτταρική Λευχαιμία
Abstract
dc:descriptionMicroenvironmental interactions of the malignant clone with bystander T cells are critical throughout the natural history of chronic lymphocytic leukemia (CLL). T cells in CLL serve as a source of trophic signals for the survival of the malignant clone. Alterations in the T cell transcriptome combined with functional exhaustion undermine cytotoxic responses against tumor cells, promoting tumor evasion and escape from immunosurveillance. T cells in CLL also display anti-tumor properties that can be unleashed under stimulation, leading to tumor control. Thus, the recruitment of activated T cells in immune responses against CLL cells represents a promising alternative form of immunotherapy. However, despite early encouraging results of immunotherapy in CLL, only a few patients will benefit and even fewer will experience durable remissions, highlighting the need for a thorough study of T cells in CLL microenvironment.The present study interrogated the T cell receptor (TR) gene repertoire, the composition of cell subpopulations and the functional dynamics of T cells in patients with CLL. In detail, immunogenetic analysis of the TR repertoire was performed in patient subgroups defined by: i) the characteristics of the clonotypic immunoglobulin of the B lymphocyte receptor (BCR IG), namely the SHM status and BcR IG stereotypy, and ii) recurrent genomic aberrations in the genome of CLL cells. Immunogenetic analysis revealed TR repertoire restriction and oligoclonal T cell expansions that persisted and expanded over time. In addition, common clonotypes were identified, shared amongst patients belonging in the same prognostic group or exclusively between CLL patients, supporting that antigen selection processes actively shape the TR repertoire in CLL. These antigens may derive from a limited range of CLL-specific antigens and/or neo-antigens on the leukemic cells. These findings were supported by the in silico prediction of T cells with specificity against neoepitopes postulated to arise from genomic lesions in the TP53 and NOTCH1 genes in the respective subgroups. Τo investigate the impact of different therapies on TR repertoire dynamics, comparative longitudinal analysis of the TR repertoire was performed at the initiation and under different treatment modalities, namely chemoimmunotherapy, or novel agents (inhibitors of BcR signaling or apoptosis). These experiments were combined with analysis of T cell subpopulations by flow cytometry. We found that treatment with novel agents led to a dynamic shift of T cell subpopulations towards activated effector-memory T cells, and we identified TR clonotypes that were retained and further expanded under treatment proportionally to the depth of the clinical response. Finally, confocal microscopy and transcriptome sequencing highlighted functional restoration of T cells after treatment, as they reversed key lesions described as a hallmark of dysfunctional T cells in CLL. In particular, treatment with BcR signaling inhibitors led to the formation of functional immune synapse between T and CLL cells, while the inhibition of the anti-apoptotic protein BCL-2 led to significant changes in the expression profile of CD8+ cells, stemming from downregulation of molecules involved in inhibitory signaling pathways. In conclusion, the present thesis offers strong evidence for the existence of specific anti-leukemic T lymphocytes in CLL targeting neo-antigens on the leukemic clone. These specific T cells display functional restoration under different therapies, further supporting current efforts for T-cell based immunotherapy towards reinvigorating immune responses against CLL cells.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vlachonikola, Elisavet
- Βλαχονικόλα, Ελισάβετ
Subjects
dc:subject × 16- Τ λεμφοκύτταρα
- Χρόνια λεμφοκυτταρική λευχαιμία (ΧΛΛ)
- Ρεπερτόριο γονιδιακών αναδιατάξεων
- Υποδοχέας των Τ λεμφοκυττάρων
- Μικροπεριβάλλον όγκου
- T cells
- Chronic lymphocytic leukemia (CLL)
- T cell receptor
- T cell receptor gene repertoire
- Tumor microenvironment
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53789